Question 1

What is the catalog number for CDK5R1 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

The catalog number for CDK5R1 CRISPRa sgRNA lentivector (set of three targets)(Human) is 15708121.

Question 2

What sizes are available for CDK5R1 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

CDK5R1 CRISPRa sgRNA lentivector (set of three targets)(Human) is available in the following size(s): 3x 1.0µg DNA.

Question 3

Is CDK5R1 CRISPRa sgRNA lentivector (set of three targets)(Human) in stock?

Accepted Answer

CDK5R1 CRISPRa sgRNA lentivector (set of three targets)(Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 5

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 6

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

CDK5R1 CRISPRa sgRNA lentivector (set of three targets)(Human)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Anti-GATA3 Antibody Picoband® (HRP Conjugate)

AKAP 95 Recombinant Rabbit Monoclonal Antibody [JE63-83]

Anti-CCL2 Antibody Picoband®, Dylight550 Conjugate

Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL

P14ARF (4C6/4), 0.2mg/mL

Progesterone Receptor (PR484), CF640R conjugate, 0.1mg/mL